313 related articles for article (PubMed ID: 16315051)
1. Diagnosis and metaphylaxis of stone disease. Consensus concept of the National Working Committee on Stone Disease for the upcoming German Urolithiasis Guideline.
Straub M; Strohmaier WL; Berg W; Beck B; Hoppe B; Laube N; Lahme S; Schmidt M; Hesse A; Koehrmann KU
World J Urol; 2005 Nov; 23(5):309-23. PubMed ID: 16315051
[TBL] [Abstract][Full Text] [Related]
2. Rational evaluation of urinary stone disease.
Hesse A; Straub M
Urol Res; 2006 Apr; 34(2):126-30. PubMed ID: 16450128
[TBL] [Abstract][Full Text] [Related]
3. Metabolic evaluation and recurrence prevention for urinary stone patients: EAU guidelines.
Skolarikos A; Straub M; Knoll T; Sarica K; Seitz C; Petřík A; Türk C
Eur Urol; 2015 Apr; 67(4):750-63. PubMed ID: 25454613
[TBL] [Abstract][Full Text] [Related]
4. [Evidence-based pharmacological metaphylaxis of stone disease].
Straub M; Hautmann RE
Urologe A; 2006 Nov; 45(11):1399-400, 1402-5. PubMed ID: 17119896
[TBL] [Abstract][Full Text] [Related]
5. [Metaphylaxis in the first occurrence of urolithiasis].
Kocvara R; Plasgura P; Petrík A; Louzenský G; Bartonícková K
Cas Lek Cesk; 2000 Dec; 139 Suppl 1():16-8. PubMed ID: 11262895
[TBL] [Abstract][Full Text] [Related]
6. [What kind of stone prevention for whom? Risk-adjusted metaphylaxis following urinary stone disease].
Straub M
Urologe A; 2006 Nov; 45(11):1387-8, 1390-1. PubMed ID: 17082926
[TBL] [Abstract][Full Text] [Related]
7. [Modern general metaphylaxis of stone disease. New risks, new evidence, new recommendations].
Siener R; Hesse A
Urologe A; 2006 Nov; 45(11):1392, 1394-8. PubMed ID: 17068668
[TBL] [Abstract][Full Text] [Related]
8. [Socioeconomic aspects of urinary calculi and metaphylaxis of urinary calculi].
Strohmaier WL
Urologe A; 2000 Mar; 39(2):166-70. PubMed ID: 10768228
[TBL] [Abstract][Full Text] [Related]
9. Dietary treatment of urinary risk factors for renal stone formation. A review of CLU Working Group.
Prezioso D; Strazzullo P; Lotti T; Bianchi G; Borghi L; Caione P; Carini M; Caudarella R; Ferraro M; Gambaro G; Gelosa M; Guttilla A; Illiano E; Martino M; Meschi T; Messa P; Miano R; Napodano G; Nouvenne A; Rendina D; Rocco F; Rosa M; Sanseverino R; Salerno A; Spatafora S; Tasca A; Ticinesi A; Travaglini F; Trinchieri A; Vespasiani G; Zattoni F;
Arch Ital Urol Androl; 2015 Jul; 87(2):105-20. PubMed ID: 26150027
[TBL] [Abstract][Full Text] [Related]
10. [Current state of metaphylaxis of urinary stones in Russian Federation].
Malkhasyan VA; Gazimiev MA; Martov AG; Gadzhiev NK; Sukhikh SO; Pushkar DY
Urologiia; 2022 Nov; (5):46-52. PubMed ID: 36382817
[TBL] [Abstract][Full Text] [Related]
11. [Economic aspects of evidence-based metaphylaxis].
Strohmaier WL
Urologe A; 2006 Nov; 45(11):1406-9. PubMed ID: 17063349
[TBL] [Abstract][Full Text] [Related]
12. Metabolic evaluation and medical management of upper urinary tract stone disease. Guidelines from the Scandinavian Cooperative Group for Urinary Stones.
Osther PJ; Grenabo L; Haraldsson G; Holmberg G; Lindell O; Mogensen P; Schultz A; Ulvik NM
Scand J Urol Nephrol; 1999 Dec; 33(6):372-81. PubMed ID: 10636576
[TBL] [Abstract][Full Text] [Related]
13. [Adjustment of urine PH as effective tool for successful metaphylaxis of urinary stone disease. phytotherapy].
Saenko VS; Lachinov EL; Zhantlisov DA; Gorbachev MI; Soltanov AA
Urologiia; 2020 Jun; (3):104-110. PubMed ID: 32597596
[TBL] [Abstract][Full Text] [Related]
14. The Urological Association of Asia clinical guideline for urinary stone disease.
Taguchi K; Cho SY; Ng AC; Usawachintachit M; Tan YK; Deng YL; Shen CH; Gyawali P; Alenezi H; Basiri A; Bou S; Djojodemedjo T; Sarica K; Shi L; Singam P; Singh SK; Yasui T
Int J Urol; 2019 Jul; 26(7):688-709. PubMed ID: 31016804
[TBL] [Abstract][Full Text] [Related]
15. Prevention of stone disease.
Porena M; Guiggi P; Micheli C
Urol Int; 2007; 79 Suppl 1():37-46. PubMed ID: 17726351
[TBL] [Abstract][Full Text] [Related]
16. Metaphylaxis of urolithiasis.
Menditto VG; Milanese G; Muzzonigro G
Arch Ital Urol Androl; 2009 Mar; 81(1):32-9. PubMed ID: 19499756
[TBL] [Abstract][Full Text] [Related]
17. [Urinary stone disease. Part V. Drugs used for metaphylaxis of urinary stone disease].
Saenko VS; Gazimiev MA; Pesegov SV; Alyaev YG
Urologiia; 2019 Jul; (3):156-164. PubMed ID: 31356030
[TBL] [Abstract][Full Text] [Related]
18. Urolithiasis: evaluation, dietary factors, and medical management: an update of the 2014 SIU-ICUD international consultation on stone disease.
Jung H; Andonian S; Assimos D; Averch T; Geavlete P; Kohjimoto Y; Neisius A; Philip J; Saita A; Shah H; Osther PJ
World J Urol; 2017 Sep; 35(9):1331-1340. PubMed ID: 28160089
[TBL] [Abstract][Full Text] [Related]
19. Economics of stone disease/treatment.
Strohmaier WL
Arab J Urol; 2012 Sep; 10(3):273-8. PubMed ID: 26558036
[TBL] [Abstract][Full Text] [Related]
20. Urolithiasis in adolescent children.
Srivastava T; Alon US
Adolesc Med Clin; 2005 Feb; 16(1):87-109. PubMed ID: 15844385
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
